Home / Diabetes In Control (page 586)

Diabetes In Control

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

The regulation of food intake is a complex process involving psychologic, social, and physiologic components. Physiologically, it is generally assumed that food intake is regulated by a central feeding drive that is later counterregulated by peripheral satiety signals that are activated during a meal. These satiety signals have been suggested …

Read More »

“On-Track Diabetes” App for Patients

OnTrack

  This app lets you log values such as glucose readings, food, exercise, and medications. Each event is entered by selecting a type (e.g., exercise), and a subtype (e.g., “swimming”) from an easily customized subtype menu. This saves time because you don’t have to type in the subtype each time. …

Read More »

Editor’s Note: New Homerun Slides on CVD

Over the past weeks we have shared some great slides on Advanced Glycation End-products, and there’s a lot linking these AGE’s to cardiovascular disease. Our publisher, Steve Freed, has been working with Stan Schwartz, MD, FACP, Clinical Associate Professor of Medicine, University of Pennsylvania, and this week we have a whole …

Read More »

SPECIAL FEATURE: GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects

alt

Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO PART 2: GLP 1 Agonist-based Therapies: How do they reduce cardiovascular risks in diabetic patients? (For Part 1, just click here.) GLP-1 Agonist-based Therapies Reduce Cardiovascular Risk Weight loss is critical …

Read More »